Baliopharm's Acquisition

Baliopharm was acquired by Alvotech on May 19, 2016.

Baliopharm is a biotechnology company focusing on the development of biosimilar therapeutics for the treatment of autoimmune diseases like rheumatoid arthritis, Crohn's disease, psoriasis and multiple…

Articles about Baliopharm's Acquisition: